ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.738,81
-0,72%
S&P 500
5.297,10
-0,21%
Dow Jones
39.869,38
-0,10%
Euro vs US Dollar
1,08675
-0,20%
Bitcoin
65.386,63
-1,32%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. EyePoint Pharmaceuticals Inc (EYPT)

  7. EyePoint Pharmaceuticals Inc (EYPT) News

EYPT EyePoint Pharmaceuticals Inc

12,52
-0,42 (-3,25%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:00:03
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
EyePoint Pharmaceuticals Inc EYPT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,42 -3,25% 12,52 22:00:03
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
12,90 12,27 13,04 12,52 12,94
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
16.5.202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
09.5.202416:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.5.202413:05EDGAR2Form 8-K - Current report
08.5.202413:00GLOBEEyePoint Pharmaceuticals Reports First Quarter 2024..
06.5.202415:25EDGAR2Form 8-K - Current report
06.5.202413:00GLOBEEyePoint Pharmaceuticals Announces Topline Data from the..
16.4.202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
02.4.202413:00GLOBEEyePoint Pharmaceuticals Expands Scientific Advisory Board..
18.3.202412:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
08.3.202419:53EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07.3.202413:05EDGAR2Form 8-K - Current report
07.3.202413:00GLOBEEyePoint Pharmaceuticals Reports Fourth Quarter and..
04.3.202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:37EDGAR2Form 3 - Initial statement of beneficial ownership of..
04.3.202413:01EDGAR2Form 8-K - Current report
04.3.202413:00GLOBEEyePoint Pharmaceuticals Announces Appointment of Ramiro..
29.2.202413:00GLOBEEyePoint Pharmaceuticals to Report Fourth Quarter and..
27.2.202413:00GLOBEEyePoint Pharmaceuticals Announces Participation at Upcoming..
22.2.202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
15.2.202403:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202418:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05.2.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202422:20GLOBEEyePoint Pharmaceuticals Announces Two Presentations of..
02.2.202422:22EDGAR2Form 144 - Report of proposed sale of securities
31.1.202413:00GLOBEEyePoint Pharmaceuticals to Present at the Guggenheim..
30.1.202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.1.202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.1.202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:25EDGAR2Form 144 - Report of proposed sale of securities
24.1.202422:17EDGAR2Form 144 - Report of proposed sale of securities
23.1.202422:42EDGAR2Form 144 - Report of proposed sale of securities
23.1.202422:19EDGAR2Form 144 - Report of proposed sale of securities
22.1.202422:19EDGAR2Form 144 - Report of proposed sale of securities
17.1.202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
11.1.202423:33EDGAR2Form 144 - Report of proposed sale of securities
11.1.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
EYPT
EyePoint Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten